Acarix AB Sustainability Reports
Acarix AB is a medical device company engaged in the provision and development of non-invasive diagnostic tools for monitoring coronary artery disease. Its core product, the CADScor System, utilizes highly sensitive acoustic technology and AI algorithms to analyze cardiac blood flow and rule out coronary risks.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300KP2XS4513DEI67
FIGI: BBG0049F1480
12 reports from 2020 to 2025
